A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
Clinical trial NCT06376045 · TERMINATED
Trial details
- NCT number
- NCT06376045
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-24
- Primary completion
- 2026-05-14
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.